Navigationslinks überspringen
GCKD facts & figures
About us
Steering committee
Coordinating center
Cooperating institutionsCooperating institutions erweitern
Regional teamsRegional teams erweitern
International cooperations
Selected publications
Legal details

German Chronic Kidney Disease - GCKD Study
(national cohort study on chronical kidney disease)

There has been little research on kidney disease progression in the past. The GCKD-Study is conducted to better understand the causes, course, risk factors and consequences of progressive kidney insufficiency in order to open up new avenues of targeted diagnostic and therapeutic possibilities

Many people are affected by kidney insufficiency.  It often takes years to get from the first mild symptoms to advanced stages of kidney impairment and end-stage renal disease.
The GCKD has enrolled a total of 5217 patients with chronic kidney disease (CKD) independent of the underlying cause; 169 nephrologists all aover Germany have helped to achieve this large number.
The objective is to prospectively monitor course and complications over a period of ten years in order to better understand the factors underlying the progression of CKD to end stage renal disease and to better protect future generations, offering a more targeted therapy.

GCKD is designed as one of the largest cohort studies worldwide and among the first ones in Europe to prospectively monitor course and complications of patients with CKD of different origins with sufficient power to understand the relations between biomarkers, course and complications.

We aim at a better prognosis and quality of life in kidney patients.




                                           © GCKD Studienzentrale, Medizinische Klinik 4 am Universitätsklinikum Erlangen















[Oktober 2015]
Substudie Ernährung: Die Rücklaufquote der Ernährungsfragebögen war sehr gut; diese liegt im Schnitt bei sehr guten 74%. Derzeit laufen die Auswertungen.

Die Substudie Carvida wurde erfolgreich in den teilnehmenden Zentren abgeschlossen. Mit der Auswertung wurde begonnen.

[März 2014]
Start der 4-Jahresvisite (FU4)

[Juli 2013]
Substudie CARVIDA startet in den Zentren Aachen, Erlangen und Würzburg.

[ab September 2012]
In Berlin, Heidelberg, Erlangen und Würzburg finden Erhebungen zur Substudie Zahngesundheit statt.

free software download of the Patient Interview Audio (PIA) Tool for quality assurance in epidemiological studies 

GCKD-biobank sample tracking

Cooperating partners